ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 101 filers reported holding ADICET BIO INC in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7 | -98.7% | 5,466 | -97.6% | 0.00% | – |
Q2 2023 | $559 | +432.4% | 230,153 | +1155.1% | 0.00% | – |
Q1 2023 | $105 | -88.1% | 18,338 | -81.4% | 0.00% | – |
Q4 2022 | $882 | -99.9% | 98,663 | +19.7% | 0.00% | -100.0% |
Q3 2022 | $1,172,000 | +5481.0% | 82,407 | +5703.3% | 0.00% | – |
Q2 2022 | $21,000 | -75.0% | 1,420 | -66.1% | 0.00% | – |
Q1 2022 | $84,000 | – | 4,184 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |